Amazon To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
This Pinterest Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Citigroup Downgrades Pactiv Evergreen to Neutral, Raises Price Target to $18
Pactiv Evergreen Analyst Ratings
Baird Maintains Pactiv Evergreen(PTVE.US) With Hold Rating, Raises Target Price to $18
Pactiv Evergreen Price Target Raised to $18 From $12 at Baird
BofA Moves to No Rating on Pactiv Evergreen After Novolex Deal
Citi Downgrades Pactiv Evergreen(PTVE.US) to Hold Rating, Raises Target Price to $18
Sector Update: Financial Stocks Decline Monday Afternoon
Update: Pactiv Evergreen Shares Rise After $6.7 Billion Acquisition Deal With Apollo's Novolex
Pactiv Evergreen Shares Are Trading Higher After the Company Announced It Will Merge With Novolex in Which Pactiv Shareholders Will Receive $18.00 per Share in Cash.
Top Midday Stories: China Probing Nvidia Over Potential Anti-Monopoly Law Breaches; Gallagher to Acquire AssuredPartners for $13.45 Billion
Express News | Trading Halt: Halt Status Updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times
Apollo's Novolex to Buy Pactiv Evergreen for $6.70 Billion
Apollo's Novolex to Buy Pactiv Evergreen for $18 a Share
Pactiv Evergreen: Transaction Supported by Funds Managed by Affiliates of Apollo, the Majority Shareholder of Novolex Since 2022, and Canada Pension Plan Investment Board, Which Will Contribute About $1B and Will Become a Significant Minority...
Pactiv Evergreen: Shareholders to Receive $18.00 Per Shr in Cash >PTVE
Press Release: Novolex and Pactiv Evergreen Inc. to Combine, Establishing a Leading Manufacturer in Food and Beverage Packaging
Express News | Trading Halt: Halted at 7:55:00 A.m. ET - Trading Halt: Halt News Pending
Pactiv Evergreen: Buy Rating Amid Growth Potential and Market Underestimation